Therawis Pharma GmbH is a privately held, profitable oncology-specialized company with offices located in Munich, Germany, and was founded in April 2014. We provide European-wide support in clinical trial development in oncology.

Therawis Pharma GmbH has founded together with clinicians and scientists of the Technical University of Munich Therawis Diagnostics GmbH in September 2015. Therawis Diagnostics is dedicated to the the development and commercialization of novel predictive diagnostic biomarker assays.

The overall strategic vision of Therawis Pharma/Diagnostics is to combine highly innovative and novel diagnostics with effective therapeutics in oncology: “The theranostic mission“.